Fingerprint
Dive into the research topics of 'Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer
Apostolia Maria Tsimberidou, Wallace Akerley, Matthias C. Schabel, David S. Hong, Cynthia Uehara, Anil Chhabra, Terri Warren, Gary G. Mather, Brent A. Evans, Deane P. Woodland, Edward A. Swabb, Razelle Kurzrock
Research output: Contribution to journal › Article › peer-review
47
Scopus
citations